Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Selective JAK1 inhibitor for arthritis, eczema and inflammatory bowel disease. | Oral JAK inhibitor for rheumatoid arthritis, eczema and alopecia areata. |
| Body system | Joints & Immunity | Joints & Immunity |
| Drug class | JAK inhibitors | JAK inhibitors |
| Supply | Prescription only | Prescription only |
| Main uses | Rheumatoid arthritis, Psoriatic arthritis, Atopic dermatitis (eczema), Crohn's disease, Ulcerative colitis | Rheumatoid arthritis, Atopic dermatitis (eczema), Alopecia areata, Hospitalised COVID-19 |
| How it works | Calms immune signalling inside cells. | Calms immune signalling inside cells. |
| Starts working | Weeks | Weeks |
| Half-life | About 8–14 hours | About 12 hours |
| Typical adult dose | 15 mg once a day (arthritis); higher doses in eczema and IBD. | 4 mg once a day (2 mg if risk factors or after response). |
| Forms | Extended-release tablet | Tablet |
| Common side effects | Upper respiratory infections, Acne, Nausea, Raised cholesterol, Cold sores | Upper respiratory infections, Raised cholesterol, Nausea, Cold sores |
| Serious side effects | Serious infections, Blood clots, Heart attack and stroke, Cancers, Bowel perforation | Serious infections, Blood clots, Heart attack and stroke, Cancers |
| Don't take if | Active serious infection; Active TB; Pregnancy; Severe liver impairment | Active serious infection; Active TB; Pregnancy; Severe liver impairment |
| Alcohol | Best to limit. Alcohol may add to liver strain. | Best to limit. Alcohol may add to liver strain. |
| Pregnancy | Usually avoidedAvoid in pregnancy. | Usually avoidedAvoid in pregnancy. |
| Breastfeeding | Usually avoidedAvoid. | Usually avoidedAvoid. |
| In use since | — | — |
| Brand names | United States: RinvoqUnited Kingdom: RinvoqIndia: Rinvoq | United States: OlumiantUnited Kingdom: OlumiantIndia: Olumiant, Bariciti, Baricitinib (generic) |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | L04AA44 | L04AA37 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker